[Gene polymorphisms leading to calcified and stenotic aortic valves]

Area of Science:

• Cardiovascular Medicine
• Genetics
• Pathophysiology

Background:

• Calcified and stenosed aortic valves are increasingly prevalent, particularly in Caucasian populations, due to rising life expectancy.
• Understanding the genetic underpinnings of aortic valve disease is crucial for developing novel therapeutic strategies beyond valve replacement.

Purpose of the Study:

• To summarize known genetic determinations and gene polymorphisms associated with calcified and stenosed aortic valves.
• To explore the pathophysiological processes involved in aortic valve disease and identify potential therapeutic targets.

Main Methods:

• Literature review of genetic alterations and gene polymorphisms linked to various aortic valve abnormalities.
• Analysis of molecular biological methods, including gene expression analyses, to understand disease mechanisms.
• Comparison of aortic valve disease pathophysiology with conditions like atherosclerotic vessel inflammation and bone formation.

Main Results:

• Various genetic factors, including autosomal, X-, and Y-chromosomal alterations, and mutations in specific genes (e.g., NOTCH-1, elastin), are associated with aortic valve disease.
• Gene polymorphisms play a role, particularly in supravalvular and bicuspid aortic valve stenoses.
• Pathophysiological similarities exist between aortic valve disease and atherosclerotic inflammation and bone formation processes.

Conclusions:

• Further research into genetic factors and pathophysiological mechanisms is essential for advancing therapeutic interventions for aortic valve disease.
• Identifying novel therapeutic drug targets requires a deeper understanding of the genetic landscape of calcified and stenosed aortic valves.